|
US10398787B2
(en)
|
2012-10-26 |
2019-09-03 |
Vrije Universiteit Brussel |
Vectors for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
CA2891510C
(en)
|
2012-11-16 |
2022-10-18 |
Transposagen Biopharmaceuticals, Inc. |
Site-specific enzymes and methods of use
|
|
CN105940013B
(zh)
|
2013-12-09 |
2020-03-27 |
桑格摩生物科学股份有限公司 |
用于治疗血友病的方法和组合物
|
|
US20170107541A1
(en)
*
|
2014-06-17 |
2017-04-20 |
Poseida Therapeutics, Inc. |
A method for directing proteins to specific loci in the genome and uses thereof
|
|
CN107427557B
(zh)
*
|
2014-08-13 |
2022-01-04 |
费城儿童医院 |
用于包装和表达变体因子viii以治疗血友病的改良表达组件
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
MX388739B
(es)
|
2015-02-06 |
2025-03-20 |
Univ North Carolina Chapel Hill |
Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
|
|
US11007280B2
(en)
|
2015-03-17 |
2021-05-18 |
Vrije Universiteit Brussel |
Optimized liver-specific expression systems for FVIII and FIX
|
|
TWI707951B
(zh)
*
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
EP3283126B1
(en)
*
|
2015-04-16 |
2019-11-06 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
EP3294309A4
(en)
*
|
2015-05-14 |
2019-01-16 |
St. Jude Children's Research Hospital, Inc. |
NUCLEIC ACID MOLECULES WITH SPACERS AND METHOD FOR USE THEREOF
|
|
US11473082B2
(en)
|
2015-06-17 |
2022-10-18 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
TW202446416A
(zh)
*
|
2015-09-24 |
2024-12-01 |
美商拜奧馬林製藥公司 |
腺相關病毒因子viii載體、相關病毒粒子及包含其之治療調配物
|
|
CA3001594A1
(en)
|
2015-10-14 |
2017-04-20 |
Audentes Therapeutics, Inc. |
Nucleic acid molecules containing spacers and methods of use thereof
|
|
MY189674A
(en)
*
|
2015-10-28 |
2022-02-24 |
Sangamo Therapeutics Inc |
Liver-specific constructs, factor viii expression cassettes and methods of use thereof
|
|
EA202190827A1
(ru)
|
2015-11-13 |
2021-11-30 |
Баксалта Инкорпорейтед |
Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a
|
|
CA3005565A1
(en)
|
2015-11-13 |
2017-05-18 |
Baxalta Incorporated |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
CA3012695A1
(en)
*
|
2016-02-01 |
2017-08-10 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
MX2018012537A
(es)
*
|
2016-04-15 |
2019-02-25 |
Univ Pennsylvania |
Terapia de genes para tratar hemofilia a.
|
|
US11191847B2
(en)
|
2016-04-15 |
2021-12-07 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treating hemophilia B
|
|
KR102625416B1
(ko)
*
|
2016-05-16 |
2024-01-15 |
다케다 파머수티컬 컴패니 리미티드 |
항-인자 ix 파두아 항체
|
|
CA3035534A1
(en)
|
2016-09-07 |
2018-03-15 |
Sangamo Therapeutics, Inc. |
Modulation of liver genes
|
|
WO2018162748A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
WO2018178067A1
(en)
|
2017-03-27 |
2018-10-04 |
Vrije Universiteit Brussel |
Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
|
|
JP2020519272A
(ja)
*
|
2017-05-09 |
2020-07-02 |
エモリー ユニバーシティー |
凝固因子変異体及びその使用
|
|
CN110945127B
(zh)
*
|
2017-05-22 |
2024-07-12 |
武田药品工业株式会社 |
用于血友病b的基因疗法的编码具有增加的表达的重组fix的病毒载体
|
|
JP7764129B2
(ja)
*
|
2017-07-10 |
2025-11-05 |
ユニキュアー アイピー ビー．ブイ． |
ヒトにおけるａａｖ遺伝子療法のための手段及び方法
|
|
US20190256867A1
(en)
|
2018-02-01 |
2019-08-22 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
|
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
|
JP7244547B2
(ja)
|
2018-02-19 |
2023-03-22 |
ホモロジー・メディシンズ・インコーポレイテッド |
Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法
|
|
US12091675B2
(en)
|
2018-07-16 |
2024-09-17 |
Takeda Pharmaceutical Company Limited |
Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
|
|
US12497632B2
(en)
|
2018-08-03 |
2025-12-16 |
Sangamo Therapeutics, Inc. |
Clinical parameters by expression of factor VIII
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
JP7529286B2
(ja)
*
|
2018-10-26 |
2024-08-06 |
フリーイェ・ユニヴェルシテイト・ブリュッセル |
肝特異的核酸調節エレメント並びにその方法及び使用
|
|
CN113164560A
(zh)
|
2018-10-26 |
2021-07-23 |
Vrije布鲁塞尔大学 |
改善基因疗法的新工具及其用途
|
|
TWI851647B
(zh)
|
2019-01-16 |
2024-08-11 |
日商武田藥品工業股份有限公司 |
用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體
|
|
US11596671B2
(en)
|
2019-02-01 |
2023-03-07 |
Takeda Pharmaceutical Company Limited |
Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression
|
|
WO2021081280A1
(en)
|
2019-10-23 |
2021-04-29 |
Shire Human Genetic Therapies, Inc. |
Adeno-associated virus vectors based gene therapy for hereditary angioedema
|
|
WO2021119357A2
(en)
|
2019-12-12 |
2021-06-17 |
Baxalta Incorporated |
Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
CA3191743A1
(en)
*
|
2020-09-16 |
2022-03-24 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing fviii therapeutics
|
|
CN111926041B
(zh)
*
|
2020-10-16 |
2020-12-25 |
广州吉妮欧生物科技有限公司 |
一种SARS-CoV-2假病毒小鼠体内包装系统及其制备方法
|
|
WO2022187671A1
(en)
*
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
|
EP4313169A4
(en)
*
|
2021-03-25 |
2025-01-08 |
The Johns Hopkins University |
Hydrodynamic gene delivery
|
|
EP4355768A1
(en)
|
2021-06-14 |
2024-04-24 |
Takeda Pharmaceutical Company Limited |
Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression
|
|
AR126660A1
(es)
|
2021-07-28 |
2023-11-01 |
Univ Brussel Vrije |
Mejorando la eficacia de la terapia génica dirigida a músculos
|
|
JP2025504404A
(ja)
|
2022-01-14 |
2025-02-12 |
アンジャリウム バイオサイエンシズ エージー |
Ｖｉｉｉ因子をコードするｄｎａ分子の組成物、それを作製する方法、及びその使用方法
|
|
EP4598590A1
(en)
*
|
2022-10-08 |
2025-08-13 |
Lingyi Biotech Co., Ltd. |
Construct for enhancing gene expression
|
|
WO2025008774A1
(en)
|
2023-07-05 |
2025-01-09 |
Takeda Pharmaceutical Company Limited |
Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
|
|
WO2025226943A1
(en)
|
2024-04-25 |
2025-10-30 |
Masonic Medical Research Laboratory |
Polynucleotide for hepatocyte expression of vestigial like protein 4 and method of use thereof
|